![]() |
|
|
Vol. 26, Issue 12, 1185-1189, December 1998
Department of Pharmaceutical Chemistry, University of California, San Francisco
| |
Abstract |
|---|
|
|
|---|
The nitric oxide synthases (NOS), although unrelated to the cytochromes P450 in terms of sequence, exhibit spectroscopic and catalytic properties strongly reminiscent of those of the P450 system. One important difference is the requirement of the NOS enzymes for tetrahydrobiopterin. The biopterin cofactor is shown by chemical studies to bind close to pyrrole ring D of the prosthetic heme group, a position confirmed recently for inducible NOS and endothelial NOS by crystal structures. The only plausible role so far for the tetrahydrobiopterin is as a transient electron donor for the activation of molecular oxygen. NADPH-derived electrons are provided to the heme by the NOS flavin domain, but the biopterin may be required to provide an electron at a faster rate than that supported by the flavin groups. Chimeras in which the reductase domains of the isoforms have been exchanged indicate that the overall rate of catalytic turnover is directly governed by the ability of the flavin domain to deliver electrons. Electron transfer from the flavin to the heme domain, and within the flavin and heme domains, is thus a critical determinant of the catalytic turnover of NOS.
| |
Introduction |
|---|
|
|
|---|
The nitric oxide synthase (NOS)1 isoforms consist of a heme domain linked to a flavoprotein by a CaM-binding peptide. The flavoprotein domain exhibits strong sequence and cofactor resemblance to cytochrome P450 (P450) reductase, but the heme domain has virtually no structural similarity to P450 other than the fact that a thiolate is coordinated to the heme iron atom. Nevertheless, the heme domain is similar to P450 in terms of spectroscopic, biochemical, and catalytic properties, and much of our understanding of the function of NOS is based on our comparatively advanced understanding of the structure and mechanism of P450. A discussion of NOS, a member of the heme-thiolate family of proteins that includes P450, is therefore appropriate within the context of a P450 symposium.
NOS catalyzes the oxidation of L-Arg to
.NO and citrulline (Stuehr, 1997
; Marletta, 1988
;
Knowles and Moncada, 1994
). Three major NOS isoforms have been
identified: NOS-I (nNOS), a form initially associated with the
brain (Bredt and Snyder, 1990
); NOS-II (iNOS), a form most closely
associated with macrophages (Xie et al., 1992
); and NOS-III
(eNOS), an isoform that is localized in epithelial cells (Pollock
et al., 1991
). All three isoforms require heme, FAD,
FMN, H4B, NADPH, O2, and CaM to be
functional (Stuehr, 1997
; Marletta, 1988
; Knowles and Moncada, 1994
;
Marletta, 1993
; Masters, 1994
). All three are also homodimers of a
polypeptide in which the heme- and H4B-binding domain is linked via a
consensus CaM-binding sequence to a flavoprotein with binding sites for one FAD, one FMN, and NADPH (McMillan et al., 1992
; White
and Marletta, 1992
; Klatt et al., 1992
; Bredt et
al., 1991
; Tayeh and Marletta, 1989
; Kwon et al.,
1989
). The isoforms differ, however, in their tissue localization,
regulation, and function. nNOS is longer than the other isoforms due to
the presence of a PDZ region at the amino terminus that is involved in
subcellular targeting of the protein (Brenman et al., 1995
),
and eNOS is distinguished by the presence of myristoylation and
palmitoylation sites at the amino terminus that serve a similar
function (Busconi and Michel, 1993
; Garcia-Cardeña et
al., 1996
). Furthermore, nNOS and eNOS are constitutive enzymes
that are regulated by the Ca2+-dependent binding
of CaM to the CaM-binding sequence. Their activity is thus
physiologically controlled by local changes in the
Ca2+ concentration (Moncada and Higgs, 1993
;
Nathan and Xie, 1994
). In contrast, iNOS binds CaM in essentially a
Ca2+-independent, irreversible manner, and its
activity is transcriptionally regulated by cytokines rather than by
changes in the Ca2+ concentration (Moncada and
Higgs, 1993
; Nathan and Xie, 1994
).
The three NOS isoforms catalyze the same two-step reaction sequence and
appear to have the same catalytic mechanism. They oxidize
L-Arg to the stable intermediate
N-hydroxy-L-arginine, and
subsequently oxidize this intermediate to NO and citrulline. Both steps
in this sequence are NADPH- and O2-dependent
(Stuehr, 1997
; Marletta, 1988
; Knowles and Moncada, 1994
). The
electrons required for the reaction flow from NADPH to the FAD, then to the FMN, and finally to the heme iron atom. The flow of electrons from
the FMN to the heme iron is gated by the binding of CaM to the
CaM-binding sequence and is therefore the locus of the
Ca2+-dependent regulation of the activities of
nNOS and eNOS (Abou-Soud and Stuehr, 1993
). Of course, the electron
flow is permanently turned on in iNOS because CaM is bound to that
isoform in an essentially irreversible manner (Cho et al.,
1992
).
| |
Comparison of NOS Active Site Structures |
|---|
|
|
|---|
In order to carry out structural and mechanistic studies, we
have developed systems for expression of the NOS isoforms in Escherichia coli and have expressed and purified the
recombinant proteins (Gerber and Ortiz de Montellano, 1995
;
Rodriguez-Crespo et al., 1996
; Gerber et al.,
1997a
and 1997b
). All of these proteins, including rat nNOS, bovine and
human eNOS, and murine and human iNOS, are obtained in a correctly
folded, heme-bound state. Successful expression of iNOS requires
co-expression of a gene coding for CaM, as the protein does not fold
correctly and is inactive in the absence of CaM co-expression (Gerber
et al., 1997b
; Fossetta et al., 1996
). CaM
co-expression is not required for the expression of nNOS or eNOS, but
the yield and quality, at least of eNOS, is higher when it is
co-expressed with CaM (Rodriguez-Crespo and Ortiz de Montellano, 1996
).
The recombinant proteins are soluble and are obtained free of H4B
because there is no H4B, and no myristoylation or palmitoylation, in
E coli.
We have employed aryldiazenes as topological probes to explore the
active sites of the NOS isoforms in much the same way that we
previously used them to characterize the topologies of cytochrome P450
enzymes (Ortiz de Montellano, 1995
). Aryldiazenes react with the heme
group of hemoproteins to form stable
-bonded aryl-iron complexes
(Fe-Ar). The absorption maxima of these aryl-iron complexes when the
iron is also thiolate ligated, as in the P450 and NOS enzymes, is at
approximately 480 nm. Formation and decay of the aryl-iron complexes is
therefore readily monitored by spectroscopic methods. Earlier studies
with the P450 enzymes demonstrated that in situ oxidation of
the aryl-iron complexes with ferricyanide causes the aryl group to
migrate from the iron to one of the four nitrogens of the heme (Ortiz
de Montellano, 1995
). This migration only occurs within the intact
active site if the iron is thiolate-ligated. The four possible
N-phenylprotoporphyrin IX isomers thus formed can be
demetallated and individually quantitated by high-performance liquid
chromatography (Swanson and Ortiz de Montellano, 1991
). Earlier studies
with the crystalline P450 enzymes show that the N-arylporphyrin isomer ratio is primarily determined by the
degree to which each of the four porphyrin nitrogens is sterically
protected by active site residues. Topological information is thus
provided by the N-aryl porphyrin regioisomer ratios, using
different aryldiazene probes; by the rates of aryl-iron complex
formation and decay; and by the changes caused by cofactors,
substrates, and inhibitors in these rates and isomer ratios (Ortiz de
Montellano, 1991
).
The three NOS isoforms react with phenyldiazene (PhN==NH) to give
phenyl-iron complexes (Gerber and Ortiz de Montellano, 1995
; Gerber
et al., 1997b
). In general, the binding of CaM stimulates the phenyldiazene reaction, whereas the binding of both
L-Arg and H4B inhibits it, as expected if the biopterin
cofactor and the substrate obstruct the entry channel or the heme site
itself. The phenyldiazene reaction is slower with eNOS than with the
other two isoforms both in the presence and absence of
L-Arg or H4B, which suggests that the eNOS active site is
smaller than those of the other two isoforms. This conclusion is
supported by the finding that 2-naphthyldiazene forms a 2-napthyl-iron
complex with nNOS and iNOS, but not eNOS, and
p-biphenyldiazene only forms the p-biphenyl-iron
complex with nNOS. The minimum height above the iron required to erect
the phenyl complex is ~5.8 Å; the 2-naphthyl complex, 7.1 Å; and
the p-biphenyl complex, ~9.9 Å. The ceiling height
directly over the iron is therefore between ~6 and 10Å, with eNOS
closer to the lower and nNOS to the higher limit.
Shift of the phenyl group from the iron to the porphyrin nitrogens
gives, with all three NOS isoforms, mixtures of the four N-phenylprotoporphyrin IX regioisomers in which the
isomer with the N-phenyl on pyrrole ring D predominates
(Gerber and Ortiz de Montellano, 1995
; Gerber et al.,
1997b
). The regioisomer ratios for the CaM-bound proteins without H4B
or L-Arg are
(NB:NA:NC:ND, where the
subscript indicates the N-phenyl pyrrole ring): nNOS, 11:12:03:74; eNOS, 04:04:11:81; and iNOS, 10:17:08:65 (Gerber et
al., 1997b
). Addition of H4B decreases the proportion of the ND
regioisomer to 41%, 47%, and 40%, respectively, for nNOS, eNOS, and
iNOS. These results indicate that, in all three isoforms, the most open
region of the active site in the absence of L-Arg and H4B
is above pyrrole ring D. Furthermore, they indicate that H4B binds
close to pyrrole ring D and thereby decreases both the rate of the
reaction with phenyldiazene and the extent to which the phenyl in the
preformed complex shifts to the nitrogen of pyrrole ring D (fig.
1). These structural inferences are
confirmed by the recent crystal structure of the L-Arg- and
H4B-containing iNOS heme domain, which shows that H4B binds in the
substrate access channel close to pyrrole ring D of the heme (Crane
et al., 1998
). A similar active site geometry is observed in
the crystal structure of eNOS (T. Poulos, personal communication,
1998).
|
| |
Role of H4B |
|---|
|
|
|---|
The reason for the absolute catalytic requirement of NOS for H4B
remains unclear. Many of the functions ascribed to H4B can be satisfied
by dihydrobiopterin, a cofactor that binds to NOS without forming a
catalytically active enzyme. The binding of H4B to H4B-free NOS causes
a shift of the heme iron atom from the low- to the high-spin state
(Rodriguez-Crespo et al., 1996
), but a similar shift is
observed with dihydrobiopterin (Presta et al., 1998
). H4B
promotes the dimerization of iNOS (Baek et al., 1993
) and
stabilizes the nNOS dimer (Klatt et al., 1995
), but it is
not required for the dimerization of eNOS (Rodriguez-Crespo et
al., 1996
; Rodriguez-Crespo and Ortiz de Montellano, 1996
). Furthermore, dihydrobiopterin is able, at least for iNOS, to promote dimerization without conveying catalytic activity to the dimer (Presta
et al., 1998
). Dihydrobiopterin, like H4B, facilitates electron transfer from the flavoprotein domain to the iron to give the
ferrous enzyme (Presta et al., 1998
). Indeed, reduction of
the ferric to the ferrous state can be observed in the complete absence
of any biopterin cofactor (fig. 2). Thus
neither the allosteric effect of H4B on the iron coordination state,
nor its dimer-stabilizing properties, nor its effect on reduction of
the ferric to the ferrous enzyme, accounts for the absolute catalytic
requirement for H4B. These results are consistent with the view that
H4B plays a critical redox role not met by dihydrobiopterin, but
efforts to identify a redox role for H4B have not been successful.
However, a recent low temperature study implies a redox role for the
biopterin cofactor and provides a possible explanation for the previous
failures to detect such a role (Bec et al., 1998
). At
30oC, Bec et al. observed a spectrum
that they assigned to the nNOS ferrous dioxy complex. This spectrum, in
the presence of H4B and L-Arg, was converted to
a new species with an absorbance maximum at 428 nm. This reaction was
much faster at
30oC than oxidation of the
flavin groups, which was only observed spectroscopically as the
temperature was raised. Furthermore, this sequence of reaction steps
resulted in the production of N-hydroxy-L-arginine. The reaction sequence is
not observed when dihydrobiopterin is used instead of H4B. These
results led the authors to propose that H4B provides the electron
required to activate the ferrous dioxygen complex and that the
biopterin radical thus formed is rapidly reduced, under normal turnover
conditions, by electron transfer from the flavin groups (fig.
3). There are ambiguities in this study,
notably the following: (a) the ferrous dioxy spectrum does not agree
with that reported earlier by stopped-flow studies (Abu-Soud
et al., 1997
), (b) the spectroscopically detected intermediate is not observed with a heme domain dimer that lacks the
flavin groups, and (c) artifacts can be introduced at low temperature
that are not pertinent to turnover at physiological temperatures.
Nevertheless, the low temperature studies provide a paradigm that may
explain the unique requirement for H4B in the catalytic function of
NOS.
|
|
| |
Electron Transfer |
|---|
|
|
|---|
The maximum rates of NO-synthesis by the three CaM-bound NOS
isoforms differ, the activities of nNOS and iNOS being comparable (500-1500
nmol·nmol
1·min
1)
but severalfold higher than that for eNOS (100-200
nmol·nmol
1·min-1)
(table 1) (Nishida and Ortiz de
Montellano, 1998
). The intrinsic ability of the flavin domain to
deliver electrons can be independently evaluated by measuring the rate
at which it reduces cytochrome c, an alternative electron acceptor
(Klatt et al., 1992
). All three isoforms reduce cytochrome
c, but in the absence of Ca2+/CaM the activities
of the constitutive nNOS and eNOS isoforms are much lower than that of
the permanently CaM-bound iNOS (table 1). When CaM binds to the
constitutive isoforms, their ability to reduce cytochrome c is greatly
increased (Klatt et al., 1992
; Heinzel et al.,
1992
). However, whereas the enhanced cytochrome c reductase activity of
CaM-bound nNOS is comparable to that of iNOS, that of CaM-bound eNOS
remains tenfold lower (table 1). It is to be noted that the rates of
cytochrome c reduction in all cases are much higher than the
corresponding rates of NO synthesis.
|
To examine the link between the intrinsic reductase activity of the
flavin domain and the overall activity of the NOS isoforms, we
constructed and characterized chimeras in which the isoform flavin
domains were interchanged. All six of the possible chimeras of this
type have been assembled and examined, but the results have only been
published for two of them: E/N, in which the eNOS heme and CaM domains
are fused to the nNOS reductase domain, and I/N, in which the iNOS heme
and CaM domains are fused to the neuronal reductase domain (Nishida and
Ortiz de Montellano, 1998
). Comparison of the NO-synthesizing and
cytochrome c-reducing activities of the chimeras with those of the
parent wild-type enzymes indicate that the intrinsic activity of the
reductase is a major determinant of the overall activity of the enzyme.
This is well-illustrated by the E/N chimera, which has a CaM-bound
cytochrome c reductase activity of ~6000
min
1, a value similar to that of CaM-bound nNOS
(~7000 min
1) and iNOS (~6000
min
1) but much higher than that of CaM-bound
eNOS (~700 min
1) (table 1). This result
indicates that the activity of the nNOS reductase domain is not
attenuated when it is placed in the context of the eNOS heme and
CaM-binding domains. More importantly, the NO-synthesizing activity of
the E/N chimera is fourfold higher than that of wild-type eNOS and
approaches the activities of wild-type nNOS and iNOS (table 1). One
clear conclusion from this study is that the ability of the reductase
domain to deliver electrons to the heme is a major limiting step in the
overall activity of the enzyme. Thus the activity of the chimeras
parallels that of the protein that provides the reductase domain (fig.
4).
|
Analysis of the effects of L-Arg and H4B on the rate of
NADPH consumption by the three wild-type isoforms and the two chimeras establishes, furthermore, that modulation of the enzyme activity by the
substrate and cofactor are exclusively mediated through interactions
with the heme domain. Thus the consumption of NADPH is greatly
stimulated by H4B and L-Arg in iNOS but not nNOS or eNOS
(fig. 5). This is also observed with the
I/N but not E/N chimera. The consumption of NADPH by H4B- and
L-Arg-free eNOS is slightly stimulated by the addition of
L-Arg and slightly depressed by the addition of H4B, in a
manner similar to the activity observed when both the cofactor and
substrate are present (Nishida and Ortiz de Montellano, 1998
). This
same pattern, which differs from those observed with nNOS and iNOS, is
observed for the E/N chimera. Analysis of the dimerization properties
of the chimeras shows that this property also resembles that of the
parent heme domain. The effects of the substrate and cofactor on NADPH
consumption are a composite of their effects on the rate of electron
transfer to the heme, the rate of autooxidation of the ferrous dioxy
complex, and the amount of NADPH consumed by uncoupled reduction of
molecular oxygen.
|
A third important feature that is affected by exchanging the reductase
domains is the insensitivity of the activity of iNOS to the
Ca2+-concentration. The activity of wild-type
iNOS remains essentially constant as the concentration of the
Ca2+-chelating agent EGTA is increased from 0 to
2.5 mM. However, the activity of the I/N chimera is no longer
insensitive to the presence of the chelating agent and exhibits a
decreased NO synthesizing activity in the presence of 100 mM EGTA,
although it is still active at the highest concentration of EGTA
examined (fig. 6) (Nishida and Ortiz de
Montellano, 1998
). Thus the protein contacts that govern the tight
association of CaM to iNOS and the apparent independence of CaM-bound
iNOS to the Ca2+-concentration involve, at least
partially, residues of the flavin domain. This finding agrees with the
conclusions of Ruan and coworkers, based on studies of nNOS and
iNOS chimeras, that sequences of iNOS in addition to those in the
consensus CaM-binding sequence are required in order to produce the
Ca2+-independence of the enzyme (Ruan et
al., 1996
).
|
We have further explored very recently the role of flavin domain
residues in controlling the Ca2+/CaM-dependent
activation of eNOS. The peptide insert identified by Salerno et
al. (Salerno et al., 1997
) in the eNOS FMN domain has
been deleted from the cDNA and the protein has been expressed and
purified. A comparison of the wild-type and insert-deleted proteins
shows that removal of the insert (a) decreases the concentration of
Ca2+ required to activate the protein in the
presence of CaM and (b) elevates the total activity of the reductase
domain as measured by its ability to reduce cytochrome c (C. Nishida
and P. Ortiz de Montellano, unpublished results, 1998).
| |
Conclusions |
|---|
|
|
|---|
Electron transfer, and control of the rate of electron transfer,
are critical in determining the activities of the NOS isoforms. The NOS
isoforms resemble P450 enzymes in this, as in many other, respects
because electron transfer to the ferrous dioxy complex is also a key
rate-determining step in the P450 systems. Indeed, H4B may be essential
for the formation of NO because it functions as a rapid
but
transient
source of electrons in the activation of oxygen by the NOS
enzymes. Although the absolute rate of catalytic turnover is determined
by the ability of the reductase domain to provide electrons, the
effects of H4B and L-Arg on electron transfer are
determined exclusively by interactions of the substrate and cofactor
with the heme domain of the protein. Control of electron transfer from
the flavin to the heme domain, and within the flavin and heme domains,
is a complex but critical aspect of the function of the NOS enzymes.
| |
Footnotes |
|---|
The work in the author's laboratory was supported by National Institutes of Health grant GM25515.
Send reprint requests to: Dr. Paul R. Ortiz de Montellano, School of Pharmacy, University of California, San Francisco, CA 94143-0446. e-mail: ortiz{at}cgl.ucsf.edu
| |
Abbreviations |
|---|
Abbreviations used are: NOS, nitric oxide synthase; CaM, Ca2+-dependent calmodulin; P450, cytochrome P450; L-Arg, L-arginine; FAD, flavin adenine dinucleotide; FMN, flavin mononucleotide; H4B, 5,6,7,8-tetrahydrobiopterin; nNOS, neuronal NOS; iNOS, inducible NOS; eNOS, endothelial NOS; heme, iron protoporphyrin IX regardless of iron coordination and oxidation state; PDZ, domains of ~80 amino acids found in structural proteins of the cytoskeleton and in enzymes that associate with the cytoskeleton, and therefore thought to be involved in protein-protein interaction (also called GLGF repeats or DHRs); E/N, chimera consisting of the eNOS heme and CaM-binding domains and the nNOS flavin domain; I/N, chimera consisting of the iNOS heme and CaM-binding domains and the nNOS flavin domain.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. Tiso, A. Strub, C. Hesslinger, C. T. Kenney, R. Boer, and D. J. Stuehr BYK191023 (2-[2-(4-Methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine) Is an NADPH- and Time-Dependent Irreversible Inhibitor of Inducible Nitric-Oxide Synthase Mol. Pharmacol., April 1, 2008; 73(4): 1244 - 1253. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tiso, D. W. Konas, K. Panda, E. D. Garcin, M. Sharma, E. D. Getzoff, and D. J. Stuehr C-terminal Tail Residue Arg1400 Enables NADPH to Regulate Electron Transfer in Neuronal Nitric-oxide Synthase J. Biol. Chem., November 25, 2005; 280(47): 39208 - 39219. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Lin, D. Fulton, R. Babbitt, I. Fleming, R. Busse, K. A. Pritchard Jr., and W. C. Sessa Phosphorylation of Threonine 497 in Endothelial Nitric-oxide Synthase Coordinates the Coupling of L-Arginine Metabolism to Efficient Nitric Oxide Production J. Biol. Chem., November 7, 2003; 278(45): 44719 - 44726. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Vasquez-Vivar, N. Hogg, P. Martasek, H. Karoui, K. A. Pritchard Jr., and B. Kalyanaraman Tetrahydrobiopterin-dependent Inhibition of Superoxide Generation from Neuronal Nitric Oxide Synthase J. Biol. Chem., September 17, 1999; 274(38): 26736 - 26742. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||